Rowland Carmichael Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Rowland Carmichael Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$23K	Sell	153 -21	-12%	-$3K	0.01%	335
2020 Q3	$24K	Buy	174 +37	+27%	+$5.02K	0.01%	312
2020 Q2	$19K	Buy	137 +116	+552%	+$14.8K	0.01%	309
2020 Q1	$2K	Hold	21	–	–	﹤0.01%	319
2019 Q4	$3K	Buy	+21	New	+$2.34K	﹤0.01%	347
2018 Q3	–	Sell	-132	Closed	-$14K	–	359
2018 Q2	$14K	Hold	132	–	–	0.01%	331
2018 Q1	$14K	Hold	132	–	–	0.01%	295
2017 Q4	$14K	Hold	132	–	–	0.01%	304
2017 Q3	$15K	Hold	132	–	–	0.01%	282
2017 Q2	$14K	Sell	132 -354	-73%	-$34.9K	0.01%	278
2017 Q1	$48K	Buy	+486	New	+$46.5K	0.03%	251
2016 Q3	–	Sell	-555	Closed	-$48K	–	296
2016 Q2	$48K	Buy	555 +255	+85%	+$22.9K	0.03%	257
2016 Q1	$26K	Buy	+300	New	+$26.8K	0.02%	186

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Rowland Carmichael Advisors's IBB Position: Q4 2020 in Review

Rowland Carmichael Advisors reduced its iShares Biotechnology ETF (IBB) stake by 12% in Q4 2020, selling an estimated $3K and leaving 153 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #335.

Rowland Carmichael Advisors first reported a position in IBB in Q1 2016 and has held it in 13 quarters since. The position peaked at $48K in Q1 2017. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

Rowland Carmichael Advisors held 153 shares of iShares Biotechnology ETF worth $23K as of Q4 2020.
Rowland Carmichael Advisors sold 21 iShares Biotechnology ETF shares in Q4 2020, an estimated $3K.
iShares Biotechnology ETF made up 0.01% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #335 holding.
Rowland Carmichael Advisors first reported a position in iShares Biotechnology ETF in Q1 2016 and has held it in 13 quarters since.
Rowland Carmichael Advisors's iShares Biotechnology ETF position peaked at $48K in Q1 2017.
856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.